Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts

• Main Authors: Alanna Kulchak Rahm (Author), Deborah Cragun (Author), Jessica Ezzell Hunter (Author), Mara M. Epstein (Author), Jan Lowery (Author), Christine Y. Lu (Author), Pamala A. Pawloski (Author), Ravi N. Sharaf (Author), Su-Ying Liang (Author), Andrea N. Burnett-Hartman (Author), James M. Gudgeon (Author), Jing Hao (Author), Susan Snyder (Author), Radhika Gogoi (Author), Ilene Ladd (Author), Marc S. Williams (Author)
• Format: Book
• Published: BMC, 2018-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/s12913-018-3636-2; 1472-6963
• Keywords: Lynch syndrome; Implementation; Qualitative comparative analysis (QCA); Consolidated framework for implementation research (CFIR); Precision medicine; Universal screening; Public aspects of medicine; RA1-1270
• Source: BMC Health Services Research, Vol 18, Iss 1, Pp 1-11 (2018)

Abstract Background Systematic screening of all colorectal tumors for Lynch Syndrome (LS) has been recommended since 2009. Currently, implementation of LS screening in healthcare systems remains variable, likely because LS screening involves the complex coordination of multiple departments and individuals across the healthcare system. Our specific aims are to (1) describe variation in LS screening implementation across multiple healthcare systems; (2) identify conditions associated with both practice variation and optimal implementation; (3) determine the relative effectiveness, efficiency, and costs of different LS screening protocols by healthcare system; and (4) develop and test in a real-world setting an organizational toolkit for LS screening program implementation and improvement. This toolkit will promote effective implementation of LS screening in various complex health systems. Methods This study includes eight healthcare systems with 22 clinical sites at varied stages of implementing LS screening programs. Guided by the Consolidated Framework for Implementation Research (CFIR), we will conduct in-depth semi-structured interviews with patients and organizational stakeholders and perform economic evaluation of site-specific implementation costs. These processes will result in a comprehensive cross-case analysis of different organizational contexts. We will utilize qualitative data analysis and configurational comparative methodology to identify facilitators and barriers at the organizational level that are minimally sufficient and necessary for optimal LS screening implementation. Discussion The overarching goal of this project is to combine our data with theories and tools from implementation science to create an organizational toolkit to facilitate implementation of LS screening in various real-world settings. Our organizational toolkit will account for issues of complex coordination of care involving multiple stakeholders to enhance implementation, sustainability, and ongoing improvement of evidence-based LS screening programs. Successful implementation of such programs will ultimately reduce suffering of patients and their family members from preventable cancers, decrease waste in healthcare system costs, and inform strategies to facilitate the promise of precision medicine. Trial registration N/A